A Cochrane review confirms what many have long warned: anti-amyloid Alzheimer’s drugs don’t work and may cause brain swelling and microbleeds. For over a decade, the amyloid-beta theory, built on a paper flagged for potential fraud, has dominated research, while the NIH has poured $1.6 billion into failing therapies and sidelined competing approaches. Meanwhile, a precision medicine protocol targeting inflammation, insulin sensitivity, toxins, and other root causes has produced sustained cognitive improvement in patients for up to eleven years. Is it time to abandon the amyloid model and fund what actually works?

Airdate: April 23, 2026